Antibody molecules which bind CD22
US11472879B2 · kind B2 · utility
1Cited by
97References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2020 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Mar 25, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.